Skip to main content
ISTH 2023 Main banner
Back

    Sandrine THOUZEAU, PhD (she/her/hers)

    PhD student
    Division of Hematology-Oncology, CHU Sainte-Justine, Université de Montréal
    Montreal, Quebec, Canada

    PhD. student in the Specialized Hemostasis Laboratory of the Sainte Justine University Hospital in Montreal.
    15 years in the National Reference Centre for Thrombotic MicroAngiopathy with participation in 5 articles:
    - Joly B, Stepanian A, Hajage D, Thouzeau S, Capdenat S, Coppo P, Veyradier A. Evaluation of a chromogenic commercial assay using VWF-73 peptide for ADAMTS13 activity measurement. Thomrb Res. 2014 Nov; 134(5):1074-80
    - Thouzeau S, Capdenat S, Stepanian A, Coppo P, Veyradier A. Evaluation of a commercial assay for ADAMTS13 activity measurement. Thromb Haemost. 2013 Oct; 110(4):852-3
    - Béranger N, Benghezal S, Savigny S, Capdenat S, Joly BS, Coppo P, Stepanian A, Veyradier A. Loss of von Willebrand factor high- molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura. Thromb Res. 2019 Sep; 181:29-35. doi: 10.1016/j.thromres.2019.07.012. Epub 2019 Jul 16
    - Demagny J, Driss A, Stepanian A, Anguel N, Affo L, Roux D, Habibi A, Benghezal S, Capdenat S, Coppo P, Driss F, Veyradier A. ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occulisve crisis of sickle cell disease. RPTH. 2020 Nov; doi: 10.1002/rth2.12460
    - Béranger N, Benghezal S (co-First), Joly B.S, Capdenat S, Delton A, Stepanian A, Coppo P, Veyradier A. Diagnosis and follow-up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay. RPTH. 2020 Oct; doi: 10.1002/rth2.12461

    Presentation(s):